Max Rosett serves as Executive at Immunome Inc., where they oversee executive responsibilities. Since joining the company, Max Rosett has executed 2 insider transactions totaling $230.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 19, 2024 involved exercising options for 42,000 shares valued at $44.1K.
Max Rosett currently holds 61,856 shares of Immunome Inc. (IMNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Max Rosett has been a net seller of IMNM stock. They have purchased $0 and sold $230.2K worth of shares.
Max Rosett's most recent insider trade was on Sep 19, 2024, when they sold 42,000 shares at $1.05 per share.
Get notified when new Form 4 filings are submitted
| $16.01 |
| Discretionary |